Enhancing the therapeutic efficacy of chimeric antigen receptor T cells for acute myeloid leukemia |
Washington University / Miriam Kim, MD |
Young Investigator Grants |
2019 |
Missouri |
Exploiting the Differentiation Potential of Pediatric High-Grade Glioma to Discover Novel Therapeutic Opportunities |
Dana-Farber Cancer Institute / Mariella Filbin, MD/PhD |
'A' Award Grants |
2019 |
Massachusetts |
Kidney Disease after CD19-Targeted Chimeric Antigen Receptor T Cell Therapy for Pediatric Acute Lymphoblastic Leukemia |
Children’s Hospital of Philadelphia / Regina Myers, MD |
Young Investigator Grants |
2019 |
Pennsylvania |
Using Splice Switching Oligonucleotides (SSOs) to target MDM2 for rhabdomyosarcoma therapy |
Research Institute at Nationwide Children's Hospital / Dawn Chandler, PhD |
Innovation Grants |
2019 |
Ohio |
Investigation of Pediatric Rhabdomyosarcoma Recurrence through Single-Cell Sequencing |
St. Jude Children’s Research Hospital / Anand Patel, MD/PhD |
Young Investigator Grants |
2019 |
Tennessee |
Therapeutic Targeting of the Disrupted Metabolic State in DIPG |
University of Michigan / Costas Lyssiotis, PhD & Sriram Venneti, MD/PhD |
Innovation Grants |
2019 |
Michigan |
Therapeutic Targets and Molecular Mechanisms in Childhood Brainstem Tumors |
University Health Network - Toronto Western Research Institute / Jerome Fortin, PhD |
Young Investigator Grants |
2019 |
Ontario |
Novel Therapy of Heterogeneous B-cell Acute Lymphocytic Leukemia by Targeting Convergent Oncogenic Mediators STATs |
University of Alberta / Hasan Uludag, PhD |
Innovation Grants |
2019 |
Alberta |
Role of the macro lncRNA KCNQ1OT1 in embryonal rhabdomyosarcoma tumorigenesis |
Duke University / Corinne Linardic, MD/PhD |
Innovation Grants |
2019 |
North Carolina |
Investigating phase separated condensates in FPD to MDS/AML progression |
Broad Institute / Zuzana Tothova, MD/PhD |
RUNX1 Early Career Investigator Grants |
2019 |
Massachusetts |